Newcardio (OTCMKTS:NWCI) and Natus Medical (OTCMKTS:BABY) Head-To-Head Review

Share on StockTwits

Newcardio (OTCMKTS:NWCI) and Natus Medical (NASDAQ:BABY) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, valuation and risk.

Risk and Volatility

Newcardio has a beta of 6.41, indicating that its stock price is 541% more volatile than the S&P 500. Comparatively, Natus Medical has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Newcardio and Natus Medical, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Newcardio 0 0 0 0 N/A
Natus Medical 0 1 1 0 2.50

Natus Medical has a consensus target price of $36.00, suggesting a potential upside of 37.67%. Given Natus Medical’s higher possible upside, analysts clearly believe Natus Medical is more favorable than Newcardio.

Valuation & Earnings

This table compares Newcardio and Natus Medical’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Newcardio N/A N/A N/A N/A N/A
Natus Medical $530.89 million 1.68 -$22.93 million $1.42 18.42

Newcardio has higher earnings, but lower revenue than Natus Medical.

Profitability

This table compares Newcardio and Natus Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Newcardio N/A N/A N/A
Natus Medical -8.62% 10.75% 6.56%

Insider & Institutional Ownership

91.6% of Natus Medical shares are owned by institutional investors. 1.7% of Natus Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Natus Medical beats Newcardio on 7 of the 9 factors compared between the two stocks.

Newcardio Company Profile

NewCardio, Inc., a cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of drugs under development. The company's technology platform provides real-time and 3-D analysis of the heart's electrical activity as detected at the body surface by standard 12-lead electrocardiogram (ECG) electrodes. Its developing products include QTinno, an automated cardiac safety solution that replaces the manual and/or semi-automated methodologies with algorithms that automatically measure, analyze, and report on the ECGs collected; and CardioBip, a mobile ECG transtelephonic system comprising a mobile ECG recording and transmitting device, and a Web enabled software which receives, processes, and analyzes the data. The company is also developing my3KG, a software application to provide a method to assess cardiac electrical activity in time and space. NewCardio, Inc. was founded in 2004 and is based in Branchburg, New Jersey.

Natus Medical Company Profile

Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing screening products; diagnostic hearing assessment products to screen for/or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; balance and mobility systems to diagnose and assist in treating balance disorders; and thermoregulation products to control the incubators and warmers. Additionally, it offers jaundice management products; brain injury products; NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation and sound rooms to hearing and balance care professionals. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Pleasanton, California.

Receive News & Ratings for Newcardio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Newcardio and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Morgan Stanley Boosts ZEALAND PHARMA/S  Price Target to $30.00
Morgan Stanley Boosts ZEALAND PHARMA/S Price Target to $30.00
Urban Outfitters  Price Target Cut to $34.00
Urban Outfitters Price Target Cut to $34.00
Morgan Stanley Lowers RISE Education Cayman  to Underweight
Morgan Stanley Lowers RISE Education Cayman to Underweight
HC Wainwright Downgrades Trillium Therapeutics  to Neutral
HC Wainwright Downgrades Trillium Therapeutics to Neutral
KeyCorp Boosts SBA Communications  Price Target to $292.00
KeyCorp Boosts SBA Communications Price Target to $292.00
SurModics  Rating Increased to Hold at BidaskClub
SurModics Rating Increased to Hold at BidaskClub


© 2006-2019 Ticker Report